Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 418, 25-27 (4 July 2002) | doi:10.1038/418025a
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
- More Challenges
- Powered by:
nature jobs
Postdoctoral Researcher
- Harvard University School of Public Health
- Boston, MA
Beamline Scientist PROXIMA 2
- Synchrotron Soleil
- Gif Sur Yvette 91190 France
Biomedicine: Stem-cell competition
Stuart H. Orkin1 & Sean J. Morrison2
Abstract
The debate continues over the relative merits of using embryonic and adult stem cells for research — and perhaps, one day, to treat patients. Two new papers look at the abilities of these remarkable cells.
Last August tiny cells in Petri dishes captivated primetime television audiences. In a carefully worded address, US President George Bush discussed the medical potential, risks and ethics of studying human embryonic stem (ES) cells.
- Stuart H. Orkin is at the Dana-Farber Cancer Institute and Children's Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
e-mail: Email: stuart_orkin@dfci.harvard.edu - Sean J. Morrison is at the Howard Hughes Medical Institute, Departments of Internal Medicine and Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan 48109, USA.
e-mail: Email: seanjm@umich.edu
To read this story in full you will need to login or make a payment (see right).
